News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

New Information on Infections Related to Heater-Cooler Devices is Revealed by Cardiothoracic Surgeons

January 23, 2017
Article

Over the last few years, a growing number of serious infections have been linked to bacteria forming in heater-cooler devices (HCDs) used in cardiac surgery operating rooms. In these cases, aerosolized bacteria, predominantly nontuberculous mycobacterium (NTM) from the HCDs, contaminated the operative field. Emerging evidence regarding the incidence and challenges of detecting the infections has triggered alarms at the Food and Drug Administration (FDA) and regulatory agencies in Europe.

Contamination can be seen in the dark area of a heater-cooler device tube. Courtesy of Keith B. Allen, MD.


Over the last few years, a growing number of serious infections have been linked to bacteria forming in heater-cooler devices (HCDs) used in cardiac surgery operating rooms. In these cases, aerosolized bacteria, predominantly nontuberculous mycobacterium (NTM) from the HCDs, contaminated the operative field. Emerging evidence regarding the incidence and challenges of detecting the infections has triggered alarms at the Food and Drug Administration (FDA) and regulatory agencies in Europe.

The latest update on the threat of NTM was presented Sunday by cardiothoracic surgeons and experts in perfusion and infectious diseases during a special session, “Heater-Cooler-Induced Infections: Practices, Protocols, and Mitigation Strategies.”

“We are just beginning to scratch the surface, even though this research has been going on for more than two years,” said Keith B. Allen, MD, of St. Luke’s Mid American Heart Institute and the University of Missouri–Kansas City, the lead author of an abstract focusing on the problem. He has worked with other experts at the request of the FDA, which organized a special conference last summer to address the problem.

The infections associated with HCDs have a latency period of up to 72 months, with a mean time of 17 months from surgery to onset of symptoms, said Neil Fishman, MD, an infectious disease expert at the University of Pennsylvania Perelman School of Medicine in Philadelphia.

The incidence of infections has been tracked in the Medical Device Report database, which collects reports from manufacturers, importers, and user facilities, as well as physicians, patients, and consumers. The database has 339 reports related to HCDs between January 2010 and August 2016. The surgical procedure involving HCDs was identified in 94 reports, and 50 percent of them involved device implants, such as left ventricular assist devices, prosthetic valves/rings, and vascular grafts.

NTM was the most frequent organism cited in the reports, and Mycobacterium chimaera was the predominate isolate. Detection is challenging because it takes two to eight weeks to grow on mycobacterial media,  Fishman said. Identifying the species requires sequencing that is performed at only a “handful of labs” in the US.

“This is a device problem, not a surgical problem,” he added.

The infections are linked to HCDs from five different manufacturers that are used in the U.S. and around the world, with 89 percent linked to one manufacturer, Allen said, emphasizing that all of the manufacturers are working with regulatory agencies to resolve the problem.

The FDA recommends that all institutions adhere to manufacturer instructions for HCDs, use only sterile or filtered water in the devices, direct HCD exhaust away from the surgical field, and remove units with signs of contamination.

The FDA and the Centers for Disease Control recommend that some HCDs manufactured before September 2014 be transitioned out of service and that patients exposed to the devices since January 1, 2012, be notified in writing about the risk of infection.

The risk of infection increases with length of exposure to NTM, which is aerosolized from the HCDs. Clinical presentations of infection include fatigue, fever, sweating, dyspnea, weight loss, and cough. Because surgical wound infections are involved, treatment includes removal of the involved device and multiple-drug therapy, Fishman said.

“We don’t know how long to treat these infections. At the least, most people are treating for nine months, but some people are extending therapy to a year or 18 months,” he said. “The outcomes are not great. In general, the overall mortality is greater than 50 percent. That is attributed almost certainly to the delayed diagnosis.”

Miguel Sousa Uva, MD, PhD, president of the European Association for Cardio-Thoracic Surgery, commented on the European experience with these infections, which were reported overseas before being identified in the US.

Larry L. Shears, MD, of Wellspan Health in Chattanooga, Tenn., first experienced NTM infections at Hershey Medical Center in York, Penn., in June 2015. He discussed patient symptoms, adding that it “appeared as though they had a malignancy.”

Kenneth G. Shann, CCP, LP, director of perfusion services at Massachusetts General Hospital in Boston, offered recommendations on properly caring for HCDs. He suggested that a checklist be used to clean devices, that cleanings be documented, and that the serial numbers of HCDs used in procedures be recorded.

STS president Joseph E. Bavaria, MD noted that the Society has issued a statement about HCDs, as well as provided advisories from the CDC and FDA, on its website at http://www.sts.org/heater-cooler/.

Source: The Society of Thoracic Surgeons

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Subscribe Now!
Recent Videos
DJ Shannon, MPH, CIC, VA-BC, FAPIC
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Anna Castillo-Gutierrez, CRCST, CSPDT, CHL, CIS, CFER,  and Maya Luera, CRCST, CIS, CER, CHL
Lucy Witt, MD
Chase Elms, BS, CRCST
Garrett Hollembeak, CRCST, CIS, CHL, CER, CIC
Related Content

Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste. (Adobe Stock 1521632893 by Maksim)

Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported

Tori Whitacre Martonicz
July 18th 2025
Article

Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.


What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness

What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness

Tori Whitacre Martonicz
July 16th 2025
Article

Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.


Operating room, surgical site infections   (Adobe Stock, Unknown)

The Next Frontier in Infection Control: AI-Driven Operating Rooms

Tori Whitacre Martonicz
Published: July 15th 2025 | Updated: July 15th 2025
Article

Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.


Weekly Rounds with Infection Control Today

Weekly Rounds: Stretcher Contamination, Lumens 2.0, and More

July 14th 2025
Article

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending July 13, 2025.


Cori L. Ofstead, MSPH; Brandon M. Gantt, MHA, CRCST, CHL, CER, LSSGBH; and Jill E. Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, CHL

Lumens 2.0 Study Results: Borescopes Reveal Hidden Challenges of Cleaning Lumened Surgical Instruments

Tori Whitacre Martonicz
July 8th 2025
Article

A groundbreaking study presented at HSPA25 and APIC25 exposed hidden contamination lurking inside orthopedic and neurosurgical instruments—even after cleaning. The Lumens 2.0 research highlights why infection prevention must look deeper than surface-level protocols.


Jill Holdsworth, CIC, FAPIC, NREMT, CRCST, CHL; and Katie Belski, BSHCA, CRCST, CHL, CIS, CER, At HSPA25

Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski

Betsy Donahue, MA
June 26th 2025
Article

In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.

Related Content

Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste. (Adobe Stock 1521632893 by Maksim)

Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported

Tori Whitacre Martonicz
July 18th 2025
Article

Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.


What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness

What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness

Tori Whitacre Martonicz
July 16th 2025
Article

Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.


Operating room, surgical site infections   (Adobe Stock, Unknown)

The Next Frontier in Infection Control: AI-Driven Operating Rooms

Tori Whitacre Martonicz
Published: July 15th 2025 | Updated: July 15th 2025
Article

Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.


Weekly Rounds with Infection Control Today

Weekly Rounds: Stretcher Contamination, Lumens 2.0, and More

July 14th 2025
Article

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending July 13, 2025.


Cori L. Ofstead, MSPH; Brandon M. Gantt, MHA, CRCST, CHL, CER, LSSGBH; and Jill E. Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, CHL

Lumens 2.0 Study Results: Borescopes Reveal Hidden Challenges of Cleaning Lumened Surgical Instruments

Tori Whitacre Martonicz
July 8th 2025
Article

A groundbreaking study presented at HSPA25 and APIC25 exposed hidden contamination lurking inside orthopedic and neurosurgical instruments—even after cleaning. The Lumens 2.0 research highlights why infection prevention must look deeper than surface-level protocols.


Jill Holdsworth, CIC, FAPIC, NREMT, CRCST, CHL; and Katie Belski, BSHCA, CRCST, CHL, CIS, CER, At HSPA25

Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski

Betsy Donahue, MA
June 26th 2025
Article

In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News